Home/Filings/4/0001213900-25-123620
4//SEC Filing

HULL ANDREW 4

Accession 0001213900-25-123620

CIK 0001728328other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 11:38 AM ET

Size

5.5 KB

Accession

0001213900-25-123620

Insider Transaction Report

Form 4
Period: 2025-12-19
HULL ANDREW
Director
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-12-19+1,7502,711 total
    Exercise: $1.29Exp: 2030-12-18Common shares (1,750 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner.

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001818252

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 11:38 AM ET
Size
5.5 KB